John N. McCormick, BS, PharmD, BCNSP

John N. McCormick, BS, PharmD, BCNSP

  • Director-Clinical Pharmacy Programs

Board Certifications



  • BS –University of Tennessee Health Science Center, Memphis, Tennessee
  • PharmD – University of Kentucky College of Pharmacy, Lexington, Kentucky

Focused Area of Practice

  • Clinical Programs


  • Employee of the Year, St. Jude Children’s Research Hospital

St. Jude Committee Service

  • Pharmacy and Therapeutics Committee
  • Institutional Review Board
  • Metabolic-Infusion Support Service Committee
  • Patient Care Committee
  • Pharmaceutical Department Residency Committee

Pharmacy Organizations/Committee Service

  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists
  • Pediatric Pharmacy Advocacy Group
  • Tennessee Pharmacists Association
  • American Society for Parenteral and Enteral Nutrition

Selected Publications

Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. The Oncologist August 5, 2016.

Pauley JL, Panetta JC, Crews KR, Pei D, Cheng C, McCormick J, Howard SC, Sandlund JT, Jeha S, Ribeiro R, Rubnitz J, Pui CH, Evans WE, Relling MV: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol June 13, 2013.

Crews K, Cross S, McCormick J, Development and implementation of a pharmacist managed clinical pharmacogenetics service. Am J Health-Syst Pharm Vol 68, Jan 15, 143-150, 2011.

Last update: January 2018